SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study.

Taylor, A; Thompson, TP; Ussher, M; Aveyard, P; Murray, RL; Harris, T; Creanor, S; Green, C; Streeter, AJ; Chynoweth, J; et al. Taylor, A; Thompson, TP; Ussher, M; Aveyard, P; Murray, RL; Harris, T; Creanor, S; Green, C; Streeter, AJ; Chynoweth, J; Ingram, W; Greaves, CJ; Hancocks, H; Snowsill, T; Callaghan, L; Price, L; Horrell, J; King, J; Gude, A; George, M; Wahlich, C; Hamilton, L; Cheema, K; Campbell, S; Preece, D (2020) Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study. BMJ Open, 10 (12). e043331. ISSN 2044-6055 https://doi.org/10.1136/bmjopen-2020-043331
SGUL Authors: Ussher, Michael Henry Harris, Teresa Jane Wahlich, Charlotte Amy

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (734kB) | Preview
[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution.

Download (147kB)

Abstract

INTRODUCTION: Smoking reduction can lead to increased success in quitting. This study aims to determine if a client-focused motivational support package for smoking reduction (and quitting) and increasing (or otherwise using) physical activity (PA) can help smokers who do not wish to quit immediately to reduce the amount they smoke, and ultimately quit. This paper reports the study design and methods. METHODS AND ANALYSIS: A pragmatic, multicentred, parallel, two group, randomised controlled superiority clinical trial, with embedded process evaluation and economics evaluation. Participants who wished to reduce smoking with no immediate plans to quit were randomised 1:1 to receive either (1) tailored individual health trainer face-to-face and/or telephone support to reduce smoking and increase PA as an aid to smoking reduction (intervention) or (2) brief written/electronic advice to reduce or quit smoking (control). Participants in both arms of the trial were also signposted to usual local support for smoking reduction and quitting. The primary outcome measure is 6-month carbon monoxide-confirmed floating prolonged abstinence following participant self-reported quitting on a mailed questionnaire at 3 and 9 months post-baseline. Participants confirmed as abstinent at 9 months will be followed up at 15 months. ETHICS AND DISSEMINATION: Approved by SW Bristol National Health Service Research Committee (17/SW/0223). Dissemination will include publication of findings for the stated outcomes, parallel process evaluation and economic evaluation in peer-reviewed journals. Results will be disseminated to trial participants and healthcare providers. TRIAL REGISTRATION NUMBER: ISRCTN47776579; Pre-results.

Item Type: Article
Additional Information: © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Keywords: clinical trials, primary care, public health
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: BMJ Open
ISSN: 2044-6055
Language: eng
Dates:
DateEvent
1 December 2020Published
27 October 2020Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
15/111/01National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
PubMed ID: 33262194
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112518
Publisher's version: https://doi.org/10.1136/bmjopen-2020-043331

Actions (login required)

Edit Item Edit Item